The funding, led by existing investors BioAdvance and Wellness Coaches, follows additional 3rd party studies by University College London and LateralDx, confirming that Senzo's Amplified Lateral Flow (ALF) platform returned greater than 98% accuracy against PCR, including in low viral-load samples
Read Press ReleaseMP Biomedicals announced it has received CE Marking (Conformite Europeenne) in the European Union for its innovative multiparameter patented Hepatitis C test - MULTISURE HCV antibody test.
Read Press Release